synAllergy is seeking experienced, entrepreneurial, and customer centric medical sales professionals to join our expanding team of Medical Group Account Executives. synAllergy's Medical Group Account Executives are responsible for the identification, closure, and pull-through of new business opportunities for synAllergy with independent and hospital owned primary care practices.
Position is home-based and can be full-time or job-share.
Compensation is 100% uncapped commission (1099) with an annual income potential of over $100,000 after the first year.
Training, sales support, and promotional materials provided along with some covered business expenses.
To be considered for this opportunity, applicants must have 2+ years of experience selling business to business health care services, medical devices, vaccines, or pharmaceuticals. Candidates must also have a 4 year BA/BS degree from an accredited institution and a valid driver's license.
Preferred candidates are those seeking an entrepreneurial medical sales opportunity with a flexible work environment and the potential for substantial earnings. They are also those who have current or past business relationships with family practice physicians, pediatricians, and health care administrators, who have a passion for B2B health care sales, who are self-starters, and or who have experience selling allergy medications.
Clinical nursing and or health care administration experience is a plus.
Selling skills, e.g. solution / consultative selling
Communication (oral, written, & presentation) skills
Tactical & strategic planning
Computer (Microsoft Word, Excel, and Power Point)
Customer relationship management (Salesforce.com)
Candidates MUST also have high integrity, outstanding professionalism, and sound judgement in decision making.
synAllergy is a business to business health care services company. We help primary care practices provide in-house percutaneous allergy testing and immunotherapy to appropriate patients suffering from seasonal or perennial allergies. Allergy services via synAllergy help primary care providers enhance the quality, continuity, and conveneince of care for their allergy patients and enable them to add new and high margin revenue streams to their business.
Allergen immunotherapy has been in clinical use for over 100 years. It is disease modifying treatment proven to improve allergy symptoms, reduce patients' reliance on allergy medications, and lower health care costs. Allergen immunotherapy has also been proven to help prevent the development of asthma in children with allergic rhinitis.
For more information about synAllergy and our services, please visit our website at www.synallergy.com.